Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-08-01
著者
-
DEROSA Giuseppe
Department of Internal Medicine and Therapeutics, University of Pavia
-
MAFFIOLI Pamela
Department of Internal Medicine and Therapeutics, University of Pavia
-
FERRARI Ilaria
Department of Internal Medicine and Therapeutics, University of Pavia
-
GRAVINA Alessia
Department of Internal Medicine and Therapeutics, University of Pavia
-
MEREU Roberto
Department of Internal Medicine and Therapeutics, University of Pavia
-
PALUMBO Ilaria
Department of Internal Medicine and Therapeutics, University of Pavia
-
Ferrari Ilaria
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Cicero Arrigo
D. Campanacci' Clinical Medicine And Applied Biotechnology Department 'g. Descovich'
-
Salvadeo Sibilla
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Mereu Roberto
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Palumbo Ilaria
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Maffioli Pamela
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Gravina Alessia
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Derosa Giuseppe
Department Of Internal Medicine And Therapeutics University Of Pavia
-
FOGARI Elena
Department of Internal Medicine and Therapeutic, Clinica Medica II, IRCCS Policlinico S. Matteo, Uni
-
Fogari Elena
Department Of Internal Medicine And Therapeutics University Of Pavia
-
Derosa Giuseppe
Department Of Internal Medicine And Therapeutics Centro Ipertensione E Fisiopatologia Cardiovascolar
-
CICERO Arrigo
Department of Internal Medicine, Aging and Kidney disease, University of Bologna
-
Cicero Arrigo
Department Of Internal Medicine Aging And Kidney Disease University Of Bologna
-
Derosa Giuseppe
Department Of Internal Medicine And Therapeutics University Of Pavia Fondazione Irccs Policlinico S
-
Fogari Elena
Department Of Internal Medicine And Therapeutics University Of Pavia Fondazione Irccs Policlinico S
-
D'angelo Angela
Department Of Internal Medicine And Therapeutics University Of Pavia Fondazione Irccs Policlinico S
-
Maffioli Pamela
Department Of Internal Medicine And Therapeutics Centro Ipertensione E Fisiopatologia Cardiovascolare University Of Pavia
関連論文
- Pioglitazone Metabolic Effect in Metformin-Intolerant Obese Patients Treated with Sibutramine
- Candesartan effect on inflammation in hypertension
- Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients : Comparison with Multi-daily Insulin Injections Therapy (MDI)
- Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension
- Serum Testosterone Levels and Arterial Blood Pressure in the Elderly
- Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin
- Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone : Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-α
- Thiazolidinedione Effects on Blood Pressure in Diabetic Patients with Metabolic Syndrome Treated with Glimepiride
- Effects of Manidipine/Delapril versus Olmesartan/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus
- Prevalence of Primary Aldosteronism among Unselected Hypertensive Patients : A Prospective Study Based on the Use of an Aldosterone/Renin Ratio above 25 as a Screening Test
- Comparison of the Effects of Valsartan and Felodipine on Plasma Leptin and Insulin Sensitivity in Hypertensive Obese Patients
- Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients : a Randomized, Double-Blind, Placebo-Controlled 12-Month Study
- Sibutramine and L-Carnitine Compared to Sibutramine Alone on Insulin Resistance in Diabetic Patients
- Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients
- Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients
- Effect of Delapril/Manidipine vs Olmesartan/ Hydrochlorothiazide Combination on Insulin Sensitivity and Fibrinogen in Obese Hypertensive Patients
- Effects of Nateglinide and Glibenclamide on Prothrombotic Factors in Naïve Type 2 Diabetic Patients Treated with Metformin: A 1-Year, Double-Blind, Randomized Clinical Trial
- Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients
- Hypertension and diabetes incidence : confounding factors
- Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome
- Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction
- Effect of Valsartan Addition to Amlodipine on Insulin Sensitivity in Overweight-Obese Hypertensive Patients
- Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension